心脏代谢疗法在心血管纤维化中塑造非编码RNA景观
Erica Floris1, Francesco Nutile1, Claudia Cozzolino1
1Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.
Metabolites
|October 28, 2025
概括
代谢药物可以通过改变非编码RNA (ncRNA) 表达来减少心脏纤维化. 这种表观遗传调节为与代谢综合征相关的心血管疾病提供了新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏代谢综合征导致心血管纤维化和心力衰竭.
- 像miRNA,lncRNA和circRNA这样的非编码RNA (ncRNA) 是纤维化疾病的关键表观遗传调节剂.
- 代谢疗法可能会影响ncRNA的表达,影响心血管纤维化.
研究的目的:
- 审查代谢疗法与心血管纤维化中的ncRNA调节之间的相互作用.
- 在这种背景下,突出显示微RNA (miRNA) 的治疗和生物标志物潜力.
主要方法:
- 在PubMed上手动策划和文献搜索有关代谢调节器和ncRNAs的研究.
- 专注于甲福明,SGLT2抑制剂,PPARγ激动剂,GLP-1受体激动剂和脂肪酸氧化抑制剂.
- 从体外,体内和临床研究中提取和分类数据.
主要成果:
- 代谢调节剂对亲纤维性ncRNA进行下调 (例如,miR-21,H19) 和对抗纤维性ncRNA进行上调 (例如,miR-29,miR-133a).
- 这些变化减弱了转化生长因子-β (TGF-β) 信号传递,减少了细胞外矩阵积累,改善了心肌顺应.
- 在各类药物中,ncRNA 轮变化与改善的纤维化相关终点相关.
结论:
- 代谢调节剂通过ncRNA调节产生抗纤维性作用.
- 这为心脏代谢疾病中的心血管纤维化提供了新的治疗策略和潜在的生物标志物.
- 准代谢-ncRNA交叉可能会导致病理性心脏重塑的精确干预.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
444
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
444
Types of RNA
9.0K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
9.0K
Formation of Muscle Fibers from Myoblasts
5.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331


